investorsinvestors
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (DEWB AG) is an investment company which specializes in young and established medium-sized companies within the region of Germany, Austria and Switzerland, focusing on the field of optical technologies and sensor systems, but including life science opportunities. DEWB provides support for strong growth companies in the form of shareholders' equity, comprehensive expertise in corporate development and a broad sector network. Since 1997 DEWB has invested more than 350 million Euros in more than 50 companies. The company's registered offices are located in Jena, one of the most successful technology and science regions in Germany. DEWB is listed on the Frankfurt Stock Exchange under the ticker symbol EFF. For more information please visit: www.dewb-vc.com
Paris-based Edmond de Rothschild Investment Partners (EdRIP) is dedicated to minority investments into privately·owned companies. It has currently 750 million Euro under management which are being invested primarily as life sciences venture capital and growth capital. Its life science team of seven professionals has over 90 years of cumulated experience in the life science industry and has a proven track record in biotechnology and medical technology investments. The team has approximately 270 million Euro under management, recently raised its 155 million Euro BioDiscovery 3 fund, which is to be invested during the next years. EdRIP is part of the group Edmond de Rothschild, Paris, France.
For more information, please visit www.edrip.fr
Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35 years, the firm has backed nearly 500 companies at different stages of development – pure creations, spin-offs, as well as turnaround situations – and worked alongside Europe’s key entrepreneurs in the technology, life sciences and cleantech sectors. With €1.1 billion of funds under management, Sofinnova Partners’ experienced team and hands-on approach in building portfolio companies through to exit have created market leaders, from landmark historical investments including Genentech, Actelion and Vistaprint to more recent successes such as CoreValve, Novexel, Fovea and Sensitive Object. With a global mindset, the firm has a sister organization in San Francisco, California.
Please visit www.sofinnova.fr for more information on Sofinnova’s team and portfolio.
The TVM Capital Life Science & Healthcare Practice currently manages committed capital of about 860 million Euros ($1.13bn) for investments in the life science and healthcare sectors from headquarters in Munich, an office in Boston and a representation in Singapore. The two sector teams build on the expertise, experience, international approach and demonstrated success of 113 investments and more than 70 exits including 37 initial public offerings of portfolio companies on Nasdaq, and the London, Frankfurt, Zurich and Vienna Stock Exchanges, and 24 trade sales. This track record of successful investing and value creation, in traditional early and late-stage life science venture as well as healthcare private equity, make the TVM Capital Life Science & Healthcare Practice a preferred partner for ambitiously growing companies in our target sectors.
The operating entity of the TVM Capital Healthcare Private Equity activities in the Middle East and Northern Africa (MENA) is TVM Capital MENA Ltd. based at the Dubai International Financial Center (DIFC), Dubai, United Arab Emirates. The firm operates the region's first Shari'a compliant and dedicated healthcare and pharmaceutical investment fund. The fund is regulated by the Dubai Financial Services Authority (DFSA).
Being one of the leading venture capital firms in Europe, Seventure manages €500m and invests since 1997 in innovative businesses with high growth potential in Information & Communication Technologies and in Life Sciences.
The Life Sciences Team invests all over Europe. Its 4 preferred sectors are Biotech & Pharmaceuticals, Medtech, Industrial Biotech & Cleantech, and Lifestyle Healthcare & nutrition. A typical investment ranges from €500k to €10 m per round, up to €20 m per company, from early to later stage.
Seventure is a subsidiary of Natixis Private Equity, the asset management company of Natixis, with over €4.2 bn in private equity investments.
More information: www.seventure.fr
IBB Beteiligungsgesellschaft provides equity financing to innovative Berlin-based companies. The firm is the regional market leader in venture capital in Berlin. IBB Beteiligungsgesellschaft was founded in 1997 as a fully owned subsidiary of Investitionsbank Berlin (IBB). The funds provided are to be used for the development and launch of innovative products and services or creative business concepts. IBB Beteiligungsgesellschaft manages the "VC Fonds Technologie Berlin" fund (€ 52m) and the "VC Fonds Kreativwirtschaft Berlin" fund (€ 30m). Both funds were started as joint initiatives of IBB and the State of Berlin. They are co-financed by the European Regional Development Fund (ERDF). Set up in 2008, VC Fonds Kreativwirtschaft Berlin is the first german venture capital fund solely aimed at companies from the creative industries. The track record of IBB Beteiligungsgesellschaft includes successful IPOs and a large number of trade sales to strategic partners.
More information: www.ibb-bet.de
NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The funds have flexibility to invest in a broad cross section of healthcare and biotechnology segments including drug products, medical devices and other healthcare segments like services. The funds are diversified by stage, from later stage to selected early stage opportunities, as well as by geography by investing predominantly in the US and in Europe.
NGN Capital's North American offices are in New York, NY, Greenwich, CT and its European office is in Heidelberg, Germany
More information: www.ngncapital.com